Key skills and competencies
David has extensive experience in the healthcare and life sciences sectors in executive and non-executive roles helping to transform and grow businesses in the US and globally.
Current external appointments
CEO, executive director and chair of Fortis Life Sciences. He also serves as a chair or non-executive director on the boards of several healthcare companies including Privia Health, LGC and AmSurg Corporation.
David is Non-Executive Chair at PathGroup.
Previous experience
David recently served as a chair or non-executive director on the boards of ZimVie (2022 - 2025) and VaxCare (2021 - 2025).
Prior to that he served as executive chair and CEO for Laboratory Corporation of America (LabCorp) from 2007 to 2019, where he helped transform LabCorp from a pure-play US testing laboratory into a leading global life sciences company and tripled its size through a combination of organic growth and strategic acquisitions.
Before joining LabCorp, David was a partner at Hogan & Hartson LLP (now Hogan Lovells) where he was a key leader in the firm’s healthcare fraud and abuse practice, representing national healthcare companies in investigations and litigation. David was previously the Chair of Health Channels and CEO of Fortis Life Sciences.
Nationality
American
Burn wound management Burn wounds are a global public health problem and a leading cause of morbidity, including prolonged hospitalisation, disfigurement and disability – often accompanied by stigma and social rejection.1 Our aim is to help mitigate the complications associated with burn wounds.
Pressure injury prevention Trusted to reduce the incidence of pressure injuries when used as part of a comprehensive prevention program, compared to standard care alone.1-3
Partial-thickness rotator cuff tears Partial-thickness tears can have a lasting impact on pain and shoulder function. When used in isolated bioinductive repair, the REGENETEN◊ Bioinductive Implant leads to tendon healing without the need for sutured repair;1-4 offering patients a faster recovery and return to activity than sutured repairs.4,5
Chondral and osteochondral knee repair Treat knee cartilage lesions and osteochondral defects in a single-stage procedure, even in the presence of mild to moderate osteoarthritis (Kellgren-Lawrence 0-3),1,2 with the porous, biocompatible CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant; shown to be clinically superior to the current surgical standard of care in level 1 clinical data.*1,2